Stereotaxis receives FDA approval for MAGiC Magnetic Interventional Ablation Catheter.

Stereotaxis, a pioneer in surgical robotics for endovascular intervention, has received FDA approval for its MAGiC Magnetic Interventional Ablation Catheter. This approval represents a significant milestone for Stereotaxis and the electrophysiology community, marking a major advance in robotic cardiac ablation technology. The MAGiC catheter is designed to support patients with complex heart rhythm disorders and serves as a foundation for continued technological and clinical progress.